which is lower than 1 5 per cent. As the size of this transaction is lower than 15 per cent, it falls under the approval authority of the Board of Directors of the Company and the Company is neither

, the related transactions in lower than 15%. The Company does not report the transactions on assets acquisition and disposition of the listed companies. Therefore, Information Memorandum on the Entry

2018, Cost of sales was 15,649 MTHB, increased by 209 MTHB comparing to 2017 or 1% as a result of greater main raw material prices despite of lower overall sales volume. Higher average Ethylene price

. This was due to lower short term loan requirement during the year resulting from the lower trade accounts receivable. In 2018 the transaction in other comprehensive income was Actuarial gain less income

% because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For the year 2018, the Company has net loss at Baht 40 .61 million which

% 3 / 5 Other incomes The company had other incomes in 2018 lower than those in 2017 approximately Baht (3.60) million. It was since that the company had gain on exchange in year 2 0 1 7 from importing

impacted by declining global demand, which has also led to a deceleration of private consumption as a result of lower employment, particularly in export- related manufacturing sectors. Elevated household

1.93 (0.03) Decreased from lower cash and cash equivalents used for operating activities Return on Equity (%) 0.59 1.97 (0.92) Decline from under performance Debt-to-Equity Ratio (x) 0.17 0.20 (0.03

reclassification of fixed costs at the new factory which incurred as a result of lower-than-normal production capacity in the amount of Baht 5.13 million as well as an increase in the related staff costs to support

increased by 14% yoy in parallel with hospital revenue. However, the cost increase was at lower rate than revenue increase. Likewise, 3Q17 hospital cost increased by 18% yoy lower than revenue growth. As a